Core Viewpoint - The company believes that its current share price does not reflect its intrinsic value or actual business prospects, prompting the board to decide on a share buyback program [1] Group 1 - The company plans to utilize its buyback authorization to repurchase shares in the open market [1] - The total amount allocated for the share buyback is not less than RMB 300 million [1]

Core Viewpoint - The company, Qizhi Group (00917), announced a share buyback plan to repurchase up to 26.2705 million shares, which represents 10% of the total issued shares as of the date of the resolution, excluding any treasury shares [1] Group 1 - The share buyback authorization will be subject to approval at the company's annual general meeting scheduled for June 20, 2025 [1] - The total value of the shares to be repurchased will not exceed HKD 300 million [1]

Core Viewpoint - The company, Qutai Group (00917.HK), announced a share buyback plan to repurchase up to 26,270,544 shares, representing 10% of the total issued shares as of the date of the buyback authorization resolution, with a maximum value of HKD 300 million [1] Group 1 - The board believes that the current trading price of the shares does not reflect their intrinsic value, presenting a good opportunity for the company to repurchase shares [1] - The board is confident that the proposed share buyback will enhance the value of the shares and improve shareholder returns [1] - The share buyback reflects the board's confidence in the long-term business prospects of the group and is expected to ultimately benefit the company and align with the overall best interests of shareholders [1]

Core Viewpoint - The company, Ningmeng Media (09857.HK), announced its decision to repurchase shares in the open market using its own funds, reflecting confidence in its business development prospects and growth potential [1] Group 1 - The board of directors decided to exercise the repurchase authorization on December 9, 2025 [1] - The company believes that the current share price does not adequately reflect its intrinsic value and business outlook [1] - The share repurchase is expected to enhance the net asset value per share and profitability, aligning with the best interests of the company and its shareholders [1]

Core Viewpoint - The company, Lingmeng Film (09857), has announced a share buyback plan, reflecting confidence in its business prospects and aiming to enhance shareholder value [1] Group 1: Share Buyback Authorization - Shareholders approved a general and unconditional authorization for the board of directors to repurchase up to 10% of the issued shares as of the annual general meeting date, which amounts to a maximum of 36.1576 million shares [1] - The board of directors decided to exercise this buyback authorization on December 9, 2025, intending to repurchase shares in the open market using the company's own funds [1] Group 2: Rationale for Buyback - The company believes that the current share trading price does not adequately reflect its intrinsic value and business outlook [1] - The share buyback is seen as a long-term confidence signal in the company's growth potential, aiming to enhance net asset value per share and profitability [1] - This action is aligned with the best interests of the company and its shareholders, expected to bring benefits and create value for shareholders [1]

董事会认为，于现况下进行本次股份购回可展示公司对自身业务展望及前景充满信心，且最终会为公司 及股东带来裨益。 一脉阳光(02522.HK)公告，公司有意不时于公开市场进一步购回公司H股，购回金额累计不超过2亿港 元(最终金额以国家外汇管理局审批金额为准)。根据购回授权，公司获准购回的H股最高数目为 24,937,807股H股，占年度股东会日期已发行H股(不包括库存股份)总数的10%。截至本公告日期，公司 已根据购回授权于前次股份购回购回合共4,446,000股H股，占购回授权项下获准购回的H股最高数目 24,937,807股的17.83%。本次股份购回将由公司的内部资源提供资金。 公司将根据公司的组织章程细则、香港联合交易所有限公司证券上市规则、公司收购、合并及股份回购 守则、中华人民共和国法律及本公司须遵守的所有其他适用法律法规，并在获得相关监管机构的批准后 (如需)进行本次股份购回。公司后续将于董事会视为适当时，注销、以库存方式持有以用于雇员激励、 出售或转让购回的H股(如有)。 ...

本文源自：财华网 建议购回将完全由公司內部资源提供资金。全球发售股份所得款项净额将不会用于建议购回。 【财华社讯】健康之路(02587.HK)公布，根据现行市况，公司拟于未来五个月內行使购回授权，于公开 市场上购回公司已发行股份，总代价不超过1亿港元。根据购回授权，购回最多87,770,480股公司股份， 相当于于股东周年大会日期已发行股份总数的10%。所购回的任何股份将作为库存股份持有，公司可根 据市场情况及集团的资本需求酌情予以注销、处置，或用作股份奖励或用作任何其他获准许用途。 ...

董事会认为，建议股份购回可提升股份价值，进而提高股东回报。此外，建议股份购回将彰显董事会对 其长期业务前景的信心，其将符合本公司及其股东的整体利益。董事会亦认为，本公司财务状况稳定， 可在进行建议股份购回的同时维持足够的财务资源以满足其持续业务增长需要。 绿茶集团(06831)发布公告，于2025年12月4日，董事会决议行使购回授权以适时于公开市场购回总价不 超过人民币1.3亿元的股份。建议股份购回的期间自董事会决议案日期起直至下列最早者：本公司下届 股东周年大会结束时、任何适用法律或本公司组织章程细则规定本公司须举行下届股东周年大会的期限 届满时或股东于股东大会上通过普通决议案撤销或修订本决议案所授予的授权时。本公司将动用其内部 资源(不包括全球发售所得款项净额)进行建议股份购回。本公司其后将在董事会认为适当的情况下注销 或以库存方式持有根据建议股份购回所购回的股份。本公司将根据本公司组织章程细则、香港联合交易 所有限公司证券上市规则、公司收购、合并及股份回购守则及所有其他适用法律法规进行建议股份购 回。 ...

Core Viewpoint - 朝聚眼科 (02219) announced a share buyback plan, reflecting confidence in its business outlook and aiming to create value for shareholders [1] Group 1: Share Buyback Announcement - The company plans to repurchase up to HKD 50 million worth of its shares starting from November 17, 2025 [1] - This decision is based on the approval from shareholders at the annual general meeting held on June 6, 2025 [1] - The board may increase the maximum repurchase amount depending on market conditions and will announce any changes in accordance with listing rules [1] Group 2: Market Reaction - Following the announcement, the stock price of 朝聚眼科 rose by 4.07%, reaching HKD 2.56, with a trading volume of HKD 1.3851 million [1]

Core Viewpoint - The company, Chaoyujian Ophthalmology (02219), announced a share buyback plan to repurchase up to HKD 50 million worth of its shares starting from November 17, 2025, following approval from shareholders at the annual general meeting on June 6, 2025 [1] Group 1 - The board believes that the share buyback demonstrates confidence in the company's business outlook and will ultimately benefit the company and create value for shareholders [1] - The board may increase the maximum buyback amount based on market conditions, with timely announcements made as necessary according to listing rules [1] - The company asserts that its current financial resources are sufficient to implement the share buyback while maintaining a robust financial position [1]